First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. - Wikidata - wikimedia - TriplyDB

First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

http://www.wikidata.org/entity/Q33971217

about

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates Teicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials.Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.Performance of CHROMagar selective medium and oxacillin resistance screening agar base for identifying Staphylococcus aureus and detecting methicillin resistance The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Malta.Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients.Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolates from Trinidad & Tobago.High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland.Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients.The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand.Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates Staphylococcus aureus clinical isolates: antibiotic susceptibility, molecular characteristics, and ability to form biofilm.Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides.First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.Evaluation of the Combined Effects of Stilbenoid from Shorea gibbosa and Vancomycin against Methicillin-Resistant Staphylococcus aureus (MRSA).

P2860

Q24646677-00EF870F-D5F8-4FFF-83A9-C08280207D02 Q24810927-A37CD733-6DC1-46DF-8196-F63726FC1B5D Q26796560-68A2DA0C-45D9-4F1D-AACF-F3BFA3A2EEF4 Q31144203-BFF33EF4-A7F4-4665-AAF2-A022C3585FD9 Q33264418-0E66A872-B3E3-4E64-A387-B1E727811E08 Q33961588-FC45932C-2CCA-4C29-BC42-F4FDF2945B1E Q34036435-00F7C68F-D229-4A79-9D76-DE61BF483F19 Q34142160-F4FA4CDB-2331-45E0-8E84-33EFCF6BA288 Q34455373-D6945C5A-4CE9-49A7-91A1-037A95FA269F Q34823746-76C53A30-5122-413A-A768-57DDBC63465E Q34983312-9F3416E0-D131-4ECC-8DB2-12EA0C979290 Q35027895-9B78EE48-5BD9-4CA8-B1F6-9204E261DFDF Q35124610-3D79330C-4B41-4728-B717-A5BE0D8B8886 Q35220832-4868A9E8-7AA9-4AA7-9C5E-388B4D2DD81C Q35541702-32F3DC48-2A98-4FCF-8A38-27D3B83E850E Q36094925-3A66F171-633F-482B-AF94-95E03D13FA34 Q36847287-415A9FC5-17F8-470B-A73A-52960D30C1AA Q36898303-4BC4BF66-E8DE-4576-97D6-1948E8E0B322 Q37058087-1D814088-349C-426D-874B-3A64FE0D7EF5 Q37256413-CF00847D-EB8A-4DD7-AC4F-33E9A2C32971 Q37809666-1D8B52D8-FA9D-40CB-9DF7-C5A5345B1E90 Q39094247-F4ACCEDB-DD65-4277-8C3D-E5DF16FBABAD Q39466478-629F217B-FFB6-413D-BB6D-B10B106A882E Q40771872-962121E3-31EB-459E-8EC5-56B83CE107D7 Q41016957-7473BDA4-041E-4F4A-97F2-EA4359C65ED2 Q41387835-17BE7989-2916-4F12-80FD-EEEE7AA8A224 Q41807543-5E6194CA-36D5-4A3C-A6EF-704B109140DD Q42922807-643929DE-6B34-4271-A411-762B3549A480

P2860

First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

http://www.wikidata.org/entity/Q33971217

description

2001 nî lūn-bûn

@nan

2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

First report of methicillin-re ...... ity to vancomycin in Thailand.

@ast

First report of methicillin-re ...... ity to vancomycin in Thailand.

@en

type

label

First report of methicillin-re ...... ity to vancomycin in Thailand.

@ast

First report of methicillin-re ...... ity to vancomycin in Thailand.

@en

prefLabel

First report of methicillin-re ...... ity to vancomycin in Thailand.

@ast

First report of methicillin-re ...... ity to vancomycin in Thailand.

@en

P1433

Q33971217-EFD20628-1974-44CB-A0E9-57ECDD671C37

P1476

Q33971217-3B7DBC4D-84A5-4A72-ADE6-94FCFB01E0C9

P2093

Q33971217-2D63B414-2EBD-4F96-B3D3-E903A00E225A

Q33971217-481D9618-C68B-4C9A-BD8D-8CCA721FDB4F

Q33971217-6871D6F6-4490-43D4-BBF5-629802948735

Q33971217-7231B5F8-5C0C-48B4-AE1B-9FF6A3A3E5DD

Q33971217-99C74E51-A46E-4270-BA6B-52886307305E

Q33971217-9C69A23E-5A7A-4A64-9772-38E20BF8297A

Q33971217-FD6C3457-9281-47B9-BB8B-0AD7EB8D991E

P2860

Q33971217-11414027-9AEC-4F8F-8CAE-5E703BB6B2BE

Q33971217-23317585-B3CE-4BED-821F-B86CF864B75B

Q33971217-26524E43-5727-417D-A8D1-0335BFE0C870

Q33971217-2FC63CFB-8069-48EB-9889-BE24B43E5B66

Q33971217-393B44FA-0FC8-4820-946E-876139DDFBBC

Q33971217-430A53F4-257B-4DB1-89F1-2C642A900805

Q33971217-5326F9F9-6CE0-4747-B34F-B10E3D3D0D15

Q33971217-59993C5E-9E4A-4006-A373-3544D5C3C793

Q33971217-5DCB6B1D-7117-403C-AAE2-DC61702B404A

Q33971217-67D1DB9F-859A-4E0F-B24E-FC72EFD782F6

P304

Q33971217-2C39949D-C646-4FFA-B92C-53ED2DC842D5

P31

Q33971217-708204C7-23C3-4BA9-8B90-F5397CD9B8E2

P356

Q33971217-AB0C70E1-29CC-47B2-9359-8D7EA3A866C5

P407

Q33971217-E2781D78-4DA6-43A4-AFD9-0E4C7F520FF1

P433

Q33971217-3486A82B-530A-492B-A0A9-91C8C5CD38DE

P478

Q33971217-54A728E9-B687-48D1-907E-ED86C4F453C3

P577

Q33971217-8939181E-9148-41CD-96DA-CBFCEDFF6EDD

P698

Q33971217-F970E563-9059-4FDD-A14B-391B8BFAFDDB

P921

Q33971217-93676079-A190-42E4-ACFF-4BC222F7D4F5

Q33971217-F4D60D0C-B25F-4487-95FE-1101DC831F7A

P932

Q33971217-5A5AEE35-0522-4EE0-AAF5-918285016DC7

P356

JCM.39.2.591-595.2001

P1433

Journal of Clinical Microbiology

P1476

First report of methicillin-re ...... ity to vancomycin in Thailand.

@en

P2093

C Dhiraputra

http://www.w3.org/2001/XMLSchema#string

K Hiramatsu

http://www.w3.org/2001/XMLSchema#string

S Danchaivijitr

http://www.w3.org/2001/XMLSchema#string

S Trakulsomboon

http://www.w3.org/2001/XMLSchema#string

T Ito

http://www.w3.org/2001/XMLSchema#string

W Susaemgrat

http://www.w3.org/2001/XMLSchema#string

Y Rongrungruang

http://www.w3.org/2001/XMLSchema#string

P2860

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.

Vancomycin-intermediate Staphylococcus aureus in Korea.

Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates

Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.

Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance

Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection.

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

P304

591-595

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.39.2.591-595.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11158112

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

87781

http://www.w3.org/2001/XMLSchema#string